We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CDXC market cap is 403.3M. The company's latest EPS is USD -0.0646 and P/E is -81.73.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19.5M | 21.2M | 22.15M | 22.74M | 25.58M |
| Operating Income | -1.15M | -168k | -731k | -256k | 1.6M |
| Net Income | -959k | 114k | -492k | -15k | 1.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.29M | 59.26M | 67.45M | 72.05M | 83.57M |
| Operating Income | -31.3M | -19.85M | -27.07M | -18.63M | -5.6M |
| Net Income | -32.15M | -19.93M | -27.13M | -16.54M | -4.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 53.48M | 54.96M | 54.08M | 54.04M | 56.52M |
| Total Liabilities | 26.18M | 26.51M | 25.13M | 23.32M | 22.15M |
| Total Equity | 27.31M | 28.46M | 28.95M | 30.72M | 34.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.25M | 38.36M | 57.84M | 54.06M | 54.96M |
| Total Liabilities | 19.8M | 21.93M | 26.11M | 25.39M | 26.51M |
| Total Equity | 20.45M | 16.42M | 31.73M | 28.67M | 28.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 6.47M | 7.12M | 295k | 31k | 3.53M |
| Investing | -122k | -143k | -41k | -53k | -74k |
| Financing | -14k | -90k | -14k | 582k | 1.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.44M | -10.6M | -24.16M | -15.1M | 7.12M |
| Investing | -249k | -165k | -409k | -334k | -143k |
| Financing | 16.88M | 8.65M | 36.09M | 7.65M | -90k |
| Market Cap | 403.3M |
| Price to Earnings Ratio | -81.73 |
| Price to Sales Ratio | 4.83 |
| Price to Cash Ratio | 14.84 |
| Price to Book Ratio | 14.17 |
| Dividend Yield | - |
| Shares Outstanding | 76.38M |
| Average Volume (1 week) | 339.18k |
| Average Volume (1 Month) | 490.37k |
| 52 Week Change | 269.23% |
| 52 Week High | 7.9738 |
| 52 Week Low | 1.36 |
| Spread (Intraday) | 0.01 (0.19%) |
| Company Name | ChromaDex Corporation |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.chromadex.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
